Lymph node positive prostate cancer: Long-term survival data after radical prostatectomy

Journal of Urology

Volumn 171, Issue 3, 2004, Pages 1128-1131

  Zwergel, Ulrike ^a   Lehmann, Jan ^a   Wullich, Bernd ^a   Schreier, Ulrich ^a   Remberger, Klaus ^a   Zwergel, Thomas ^a   Stoeckle, Michael ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Lymph nodes; Prostate; Prostatectomy; Prostatic neoplasms; Survival

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; CANCER HORMONE THERAPY; CANCER SURVIVAL; DISEASE COURSE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; REVIEW; TREATMENT OUTCOME;

EID: 1542357744     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000113202.37783.1f     Document Type: Article

References (21)

1. Zincke, H., Lau, W., Bergstralh, E. and Blute, M. L.: Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer. J Urol, 166: 2208, 2001
2. Schroeder, F. H., Kurth, K. H., Fossa, S. D., Hoekstra, W. J., Karthaus, H. M., Dubois, M. et al: Early versus delayed endocrine treatment in pN1-3 MO prostate cancer without local treatment of the primary tumor-results of EORTC 30846-a phase III study. J Urol, suppl., 169: 398, abstract 1487, 2003
3. Kramolowsky, E. V.: The value of testosterone deprivation in stage D1 carcinoma of the prostate. J Urol, 139: 1242, 1988
4. Studer, U.: Role of lymphadenectomy in cancer of the prostate and bladder. AUA lecture 2002
5. Bader, P., Burkhard, F. C., Markwalder, R. and Studer, U. E.: Disease progression and survival of patients with lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol, 169: 849, 2003
6. deKernion, J. B., Neuwirth, H., Stein, A., Dorey, F., Stenzl, A., Hannah, J. et al: Prognosis of patients with stage D1 prostate carcinoma following prostatectomy with and without early endocrine therapy. J Urol, 144: 700, 1990
7. Frohmueller, H. G., Theiss, M., Manseck, A. and Wirth, M. P.: Survival and quality of life of patients with stage D1 (T1-3 pN1-2M0) prostate cancer. Radical prostatectomy plus androgen deprivation versus androgen deprivation alone. Eur Urol, 27: 202, 1995
8. Seay, T. M., Blute, M. L. and Zincke, H.: Long-term outcome in patients with pTxN+ adenocarcinoma of prostate treated with radical prostatectomy and early androgen ablation. J Urol, 159: 357, 1998
9. Messing, E. M., Manola, J., Sarosdy, M., Wilding, G., Crawford, E. D. and Trump, D.: Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med, 341: 1781, 1999
10. Ghavamian, R., Bergstralh, E. J., Blute, M. L., Slezak, J. and Zincke, H.: Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ prostate cancer: a matched comparison. J Urol, 161: 1223, 1999
11. van den Ouden, D. and Schroeder, F. H.: Management of locally advanced prostate cancer. 1. Staging, natural history, and results of radical surgery. World J Urol, 18: 194, 2000
12. Cheng, L., Zincke, H., Blute, M. L., Bergstralh, E. J., Scherer, B. and Bostwick, D. G.: Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer, 91: 66, 2001
13. Kaplan, E. L. and Meier, P.: Nonparametric estimation from incomplete observations. JASA, 53: 457, 1958
14. Grimm, M. O., Kamphausen, S., Hugenschmidt, H., Stephan-Odenthal, M., Ackermann, R. and Vogeli, T. A.: Clinical outcome of patients with lymph node positive prostate cancer after radical prostatectomy versus androgen deprivation. Eur Urol, 41: 628, 2002
15. Cheng, W. S., Bergstralh, E. J. and Zincke, H.: Stage D1 prostate cancer. A nonrandomized comparison of conservative treatment options versus radical prostatectomy. Cancer, 71: 996, 1993
16. Cadeddu, J. A., Partin, A. W., Epstein, J. I. and Walsh, P. C.: Stage D1 (T1-3, N1-3, MO) prostate cancer: a case-controlled comparison of conservative treatment versus radical prostatectomy. Urology, 50: 251, 1997
17. Messing, E. M., Manola, J., Sarosdy, M., Wilding, G., Crawford, E. D. and Trump, D.: Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node positive prostate cancer: results at 10 years of EST 3886. J Urol, suppl., 169: 396, abstract 1480, 2003
18. Walsh, P. C.: Re: Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. J Urol, 164: 246, 2000
19. Schmid, H. P., Mihatsch, M. J., Hering, F. and Rutishauser, G.: Impact of minimal lymph node metastasis on long-term prognosis after radical prostatectomy. Eur Urol, 31: 11, 1997
20. Partin, A. W., Hanks, G. E., Klein, E. A., Moul, J. W., Nelson, W. G. and Scher, H. I.: Prostate-specific antigen as a marker of disease activity in prostate cancer. Oncology, 16: 1024, 2002
21. Aus, G., Nordenskjold, K., Robinson, D., Rosell, J. and Varenhorst, E.: Prognostic factors and survival in nodepositive (N1) prostate cancer - a prospective study based on data from a Swedish population-based cohort. Eur Urol, 43: 627, 2003